×
About 1,155 results

ALLMedicine™ Gynecomastia Center

Research & Reviews  349 results

Long-term survival after choriocarcinoma transmitted by liver graft: A successful repor...
https://doi.org/10.1111/petr.14135
Pediatric Transplantation; Pessanha I, Heitor F et. al.

Sep 7th, 2021 - LT is the standard of care for many pediatric liver disorders. Although long-term outcomes have improved, some rare complications such as transmission of occult donor tumors have been reported. An adolescent diagnosed with tyrosinemia was submitte...

Surgical management of complicated gynecomastia (associated with foreign body injection...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183742
Medicine Wen TC, Lai HW et. al.

Jun 5th, 2021 - Gynecomastia is a common benign breast disorder in men. Surgical management of gynecomastia includes that of a subcutaneous mastectomy with or without concurrent liposuction. Herein, the authors presented a case of complicated gynecomastia (gyneco...

Imaging in gynecomastia.
https://doi.org/10.1111/andr.13051
Andrology Billa E, Kanakis GA et. al.

May 26th, 2021 - Gynecomastia (GM) is the benign proliferation of glandular tissue in the male breast. It is a common condition, which may occur physiologically and shows three age peaks during a male's lifespan: infancy, puberty, and senescence. An underlying pat...

'H-syndrome': a multisystem genetic disorder with cutaneous clues.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8098951
BMJ Case Reports; Mori KS, Balachandran K et. al.

May 6th, 2021 - We present a case of a 25-year-old man who came to our Endocrine Clinic for evaluation of short stature. He had a history of sensorineural hearing loss, hypertrichosis and hyperpigmentation with the thickening of the skin below the hip, gynecomast...

see more →

Guidelines  1 results

ACR Appropriateness Criteria® Evaluation of the Symptomatic Male Breast.
https://doi.org/10.1016/j.jacr.2018.09.017
Journal of the American College of Radiology : JACR; , Niell BL et. al.

Nov 6th, 2018 - Although the majority of male breast problems are benign with gynecomastia as the most common etiology, men with breast symptoms and their referring providers are typically concerned about whether or not it is due to breast cancer. If the differen...

see more →

Drugs  71 results see all →

Clinicaltrials.gov  1 results

Effect of GTx-758 on Total and Free Testosterone Levels in Men With Prostate Cancer
https://clinicaltrials.gov/ct2/show/NCT01326312

Feb 4th, 2021 - Prostate cancer is one of the most frequently diagnosed noncutaneous cancers among men in the US and is the second most common cause of cancer deaths. Patients with advanced prostate cancer undergo androgen deprivation therapy (ADT), by either LHR...

see more →

News  39 results

Darolutamide Demonstrates Favorable Tolerability in Nonmetastatic CRPC
https://www.onclive.com/view/darolutamide-demonstrates-favorable-tolerability-in-nonmetastatic-crpc

Jul 12th, 2021 - Treatment with darolutamide (Nubeqa) induced a low cumulative incidence of hormone treatment–related adverse effects (HTR AEs) that was comparable to treatment with placebo in patients with nonmetastatic castration-resistant prostate cancer (CRPC)...

Bipolar Androgen Therapy Demonstrates Comparable Efficacy With Enzalutamide in mCRPC
https://www.onclive.com/view/bipolar-androgen-therapy-demonstrates-comparable-efficacy-with-enzalutamide-in-mcrpc

Mar 11th, 2021 - Bipolar androgen therapy demonstrated clinically meaningful activity and a good safety profile compared with enzalutamide (Xtandi) in asymptomatic men with metastatic castration-resistant prostate cancer (mCRPC) who progressed on abiraterone aceta...

Managing the Side Effects of Androgen-Deprivation Therapy
https://www.onclive.com/view/managing-the-side-effects-of-androgen-deprivation-therapy

Dec 5th, 2020 - Androgen-deprivation therapy (ADT) is a widely accepted treatment for men with advanced or metastatic prostate cancer. The goal of ADT is to reduce testosterone production to castrate levels, and this can be achieved surgically via orchiectomy or ...

J&J shares fall but $8 billion jury award likely to be slashed
https://www.reuters.com/article/us-johnson-johnson-risperdal/jj-shares-fall-but-8-billion-jury-award-likely-to-be-slashed-idUSKBN1WO1MW

Oct 9th, 2019 - (Reuters) - Johnson & Johnson (JNJ.N) shares were off more than 2% on Wednesday, a day after a U.S. jury said it must pay $8 billion in punitive damages to a plaintiff in a case involving its anti-psychotic drug Risperdal, a penalty the company an...

Morning Break: Alarming Rise in STDs; Script-Free PrEP; Kids and Guns
https://www.medpagetoday.com/infectiousdisease/stds/82633

Oct 9th, 2019 - Note that some links may require subscriptions. The CDC sounded the alarm over a continuing rise in the incidence of three sexually transmitted infections -- gonorrhea, chlamydia, and syphilis -- including a dramatic increase in newborn deaths rel...

see more →

Patient Education  1 results see all →